Sub Heading

Clinical Trials Details

Immune Checkpoint Inhibitor Toxicity (I-CHECKIT): A Prospective Observational Study

IRB Protocol Number
S2013

Clinical Trial Categories

  • Solid Tumors
Contact
Clinical Trials at 910-715-2200
How to Participate

Eligibility: Men or women age 18 and older, planning to receive immunotherapy only for a solid tumor malignancy.

Contact Us

For more information on participating in a clinical trial, contact us at 910-715-2200 or talk to your doctor.